N-803: a double-edged sword in haplo-NK therapy
Blood
.
2022 Feb 24;139(8):1122-1124.
doi: 10.1182/blood.2021014789.
Authors
Daniela Pende
1
,
Raffaella Meazza
1
Affiliation
1
IRCCS Ospedale Policlinico San Martino.
PMID:
35201335
DOI:
10.1182/blood.2021014789
No abstract available
Publication types
Editorial
Comment
MeSH terms
Killer Cells, Natural*
Recombinant Fusion Proteins
Substances
ALT-803
Recombinant Fusion Proteins